Cargando…

Hereditary cancer risk assessment: essential tools for a better approach

Hereditary cancer risk assessment (HCRA) is a multidisciplinary process of estimating probabilities of germline mutations in cancer susceptibility genes and assessing empiric risks of cancer, based on personal and family history. It includes genetic counseling, testing and management of at-risk indi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomy, Israel, Estevez Diz, Maria Del Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231335/ https://www.ncbi.nlm.nih.gov/pubmed/24165150 http://dx.doi.org/10.1186/1897-4287-11-16

Ejemplares similares

Hereditary cancer risk assessment: insights and perspectives for the Next-Generation Sequencing era
por: Gomy, Israel, et al.
Publicado: (2016)

Editorial: Hereditary Cancer Risk Assessment: New Perspectives and Challenges for the Next-Gen Sequencing Era
por: Gomy, Israel
Publicado: (2016)

Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer
por: Simoes Correa-Galendi, Julia, et al.
Publicado: (2020)

Ovarian cancer risk assessment in the era of next-generation sequencing
por: Bonadio, Renata Colombo, et al.
Publicado: (2020)

Bringing a humanistic approach to cancer clinical trials
por: Arai, Roberto Jun, et al.
Publicado: (2017)

Assessment of morbidity in gynaecologic oncology laparoscopy and identification of possible risk factors
por: Peña-Fernández, Maite, et al.
Publicado: (2015)

Zika Virus in a Patient With Cancer: How Much Do We Know?
por: Hepner, Adriana, et al.
Publicado: (2016)

Perspectives on PARP Inhibitor Combinations for Ovarian Cancer
por: Bonadio, Renata Colombo, et al.
Publicado: (2021)

The prognostic role of microRNA in epithelial ovarian cancer: a systematic review of literature with an overall survival meta-analysis
por: Ferreira, Patricia, et al.
Publicado: (2020)

Multiple Criteria Decision Analysis (MCDA) for evaluating cancer treatments in hospital-based health technology assessment: The Paraconsistent Value Framework
por: Campolina, Alessandro Gonçalves, et al.
Publicado: (2022)

Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management
por: da Cunha Colombo Bonadio, Renata Rodrigues, et al.
Publicado: (2018)

Management of cervical cancer patients during the COVID-19 pandemic: a challenge for developing countries
por: del Pilar Estevez-Diz, Maria, et al.
Publicado: (2020)

Immune checkpoint inhibitors: here to stay
por: Carvalho, Filomena Marino, et al.
Publicado: (2023)

Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool
por: Garutti, Mattia, et al.
Publicado: (2023)

Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer
por: Manna, Eliza Del Fiol, et al.
Publicado: (2023)

Integrated care pathway for rectal cancer treatment: cross-sectional post-implementation study using a logic model framework
por: Kobayashi, Silvia Takanohashi, et al.
Publicado: (2020)

Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?
por: Ma, Lin-Lu, et al.
Publicado: (2020)

Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies
por: Barrios, Carlos, et al.
Publicado: (2021)

Late Isolated Central Nervous System Relapse from Ovarian Serous Adenocarcinoma: A Case Report and Literature Review
por: de Castria, Tiago Biachi, et al.
Publicado: (2014)

Multigene Panel Testing for Hereditary Cancer Risk
por: Grissom, Alyssa A., et al.
Publicado: (2016)

Validation of a digital identification tool for individuals at risk for hereditary cancer syndromes
por: Bucheit, Leslie, et al.
Publicado: (2019)

Hereditary Women’s Cancer: Management and Risk-Reducing Surgery
por: Conte, Carmine, et al.
Publicado: (2023)

Evaluation of a Four-Gene Panel for Hereditary Cancer Risk Assessment
por: Secondino, Angela, et al.
Publicado: (2022)

Risk assessment tools in criminal justice and forensic psychiatry: The need for better data
por: Douglas, T., et al.
Publicado: (2017)

Hereditary cancer syndromes
por: Imyanitov, Evgeny N, et al.
Publicado: (2023)

Better assessment of physical function: item improvement is neglected but essential
por: Bruce, Bonnie, et al.
Publicado: (2009)

Hereditary angioedema: how to approach it at the emergency department?
por: Serpa, Faradiba Sarquis, et al.
Publicado: (2021)

Stafne’s bone defect in a metastatic prostate cancer patient: A diagnostic conundrum
por: da Silva, Wagner-Gomes, et al.
Publicado: (2018)

Gene Therapy in Hereditary Retinal Dystrophies: The Usefulness of Diagnostic Tools in Candidate Patient Selections
por: Malvasi, Mariaelena, et al.
Publicado: (2023)

Fall Risk Assessment Tools for Elderly Living in the Community: Can We Do Better?
por: Palumbo, Pierpaolo, et al.
Publicado: (2015)

Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?
por: Wang, Jennifer M., et al.
Publicado: (2022)

Hereditary Cancer Risk Assessment: Challenges for the Next-Gen Sequencing Era
por: Pinheiro, Hugo, et al.
Publicado: (2015)

Hereditary pancreatic cancer
por: Abe, Kodai, et al.
Publicado: (2021)

Drug therapy for hereditary cancers
por: Imyanitov, Evgeny N, et al.
Publicado: (2011)

Hereditary breast and ovarian cancer
por: Gronwald, Jacek, et al.
Publicado: (2008)

The Pathology of Hereditary Breast Cancer
por: Honrado, Emiliano, et al.
Publicado: (2004)

Impact of the COVID-19 pandemic on breast and cervical cancer stage at diagnosis in Brazil
por: Bonadio, Renata Colombo, et al.
Publicado: (2021)

Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshell
por: El Rami, Fadi E., et al.
Publicado: (2020)

Hereditary Diffuse Gastric Cancer: Molecular Genetics, Biological Mechanisms and Current Therapeutic Approaches
por: Cosma, Lidia-Sabina, et al.
Publicado: (2022)

Pancreatic cancer risk in hereditary pancreatitis
por: Weiss, Frank U.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c124f1d1osd0d5e4m3rvv1naii